Science Explorer Back to mapMap
Discussion
Researcher · Teva Pharmaceuticals (Israel) · Israel

Anna Elgart

Anna Elgart publishes mostly in Psychiatry and Mental health, Molecular Biology and Pharmacology, on topics such as Schizophrenia research and treatment, Treatment of Major Depression and Pharmaceutical studies and practices.

OpenAlex
World rank
#3,091,846
of 7,710,434 ranked researchers
Rank in Israel
#19,777
of 38,292
Works
31
Citations
393
Citations per work
12.7
h-index
9
i10-index 9Top 69% in Psychiatry and Mental health
Anna Elgart

What does Anna Elgart research?

Anna Elgart's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (11%), Pharmacology, Toxicology and Pharmaceutics (10%).

Everything else: 13 works · 40.5% of their workHealth Sciences: 12 works · 38.2% of their workMedicine: 12 works · 38.2% of their workPsychiatry and Mental health: 6 works · 19.1% of their workPharmacology: 3 works · 10.1% of their workPediatrics, Perinatology and Child Health: 2 works · 5.6% of their workOncology: 1 works · 3.4% of their workLife Sciences: 7 works · 21.3% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 11.2% of their workMolecular Biology: 3 works · 11.2% of their workPharmacology, Toxicology and Pharmaceutics: 3 works · 10.1% of their workPharmaceutical Science: 3 works · 10.1% of their workTHEIR WORKAnna Elgart31works
Life Sciences21%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1340.5%
    1. Medicine1238.2%
    1. Biochemistry, Genetics and Molecular Biology311.2%
    2. Pharmacology, Toxicology and Pharmaceutics310.1%
  1. 1Psychiatry and Mental health19% of their works
  2. 2Molecular Biology11% of their works
  3. 3Pharmacology10% of their works
  4. 4Pharmaceutical Science10% of their works
  5. 5Pediatrics, Perinatology and Child Health6% of their works
  6. 6Oncology3% of their works

Research topics

Which keywords describe Anna Elgart's research?

The keywords of their largest research topics: Antipsychotic Drugs, Neurocognitive Deficits, Antidepressant, Depression, Off-Label Drug Use, Pediatric Pharmacokinetics, Chitosan and Nanoparticles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. Antipsychotic Drugs121 topic
  2. Neurocognitive Deficits121 topic
  3. Antidepressant81 topic
  4. Depression81 topic
  5. Off-Label Drug Use51 topic
  6. Pediatric Pharmacokinetics51 topic
  7. Chitosan41 topic
  8. Nanoparticles41 topic
  9. Adaptive Designs31 topic
  10. Cyclic Nucleotide Phosphodiesterases31 topic
  11. Cyclodextrins31 topic
  12. Epilepsy31 topic
  13. False Discovery Rate31 topic
  14. Seizures31 topic
  15. Solid Dispersions31 topic
  16. cAMP Signaling31 topic

Where does Anna Elgart work?

Anna Elgart's main affiliation in the publication record is Teva Pharmaceuticals (Israel), Israel.

How many publications and citations does Anna Elgart have?

OpenAlex counts 31 works and 393 citations for Anna Elgart, an h-index of 9, ranking #3,091,846 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Anna Elgart. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.